[Prader-Willi syndrome--clinical picture and genetics]
- PMID: 7725549
[Prader-Willi syndrome--clinical picture and genetics]
Abstract
Characteristics are hypotonia, problems with feeding and thriving in the neonate and infant, later hyperphagia and severe obesity. Other findings are dysmorphic traits, hypogonadism, short stature, developmental delay, mental retardation and behavioural problems. Diabetes mellitus (NIDDM) is frequent in adults. Treatment is symptomatic. Prognosis is determined by obesity. PWS occurs almost always sporadically and is found in all ethnic groups and in both sexes. The epidemiology of PWS in Denmark is unknown. In 95% of cases with PWS cytogenetic and molecular genetic investigations show either deletion of the paternal chromosome 15q11q13 or uniparental maternal disomy of chromosome 15. Since 1992 150 bloodsamples of patients suspected for PWS have been investigated by cytogenetic and molecular genetic techniques at the John F. Kennedy Institute, DK-2600 Glostrup; deletion of the paternal chromosome 15 was found in 15 and uniparental maternal disomy of chromosome 15 in eight cases.
Similar articles
-
Molecular diagnosis of Prader-Willi syndrome.J Med Assoc Thai. 2003 Aug;86 Suppl 3:S510-6. J Med Assoc Thai. 2003. PMID: 14700141
-
Neonatal presentation of Prader Willi sindrome. Personal records.Minerva Pediatr. 2007 Dec;59(6):817-23. Minerva Pediatr. 2007. PMID: 17978792
-
[A clinical, cytogenetic and molecular study of 10 patients with the Prader-Willi syndrome].Med Clin (Barc). 1997 Mar 1;108(8):304-6. Med Clin (Barc). 1997. PMID: 9121208 Spanish.
-
[Diagnosis of Prader-Willi syndrome. Considerations on a case of erroneous diagnosis].Pediatr Med Chir. 2001 May-Aug;23(3-4):191-6. Pediatr Med Chir. 2001. PMID: 11723857 Review. Italian.
-
Interstitial 6q deletion with a Prader-Willi-like phenotype: a new case and review of the literature.Eur J Paediatr Neurol. 2000;4(1):39-43. doi: 10.1053/ejpn.1999.0259. Eur J Paediatr Neurol. 2000. PMID: 10701104 Review.
Cited by
-
Apo-Ghrelin Receptor (apo-GHSR1a) Regulates Dopamine Signaling in the Brain.Front Endocrinol (Lausanne). 2014 Aug 18;5:129. doi: 10.3389/fendo.2014.00129. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25183960 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical